uses for tirzepatide What Is Tirzepatide? How It Works & What to Expect Mounjaro (Tirzepatide) for Medical Weight

In late 2024, the FDA determined that the tirzepatide shortage had ended

Evaluated for changes in body weight, fat mass, and waist circumference in obesity-related models

On average, weight loss with Mounjaro is around 5-10% of body weight over 3-6 months

Rubbing disperses the medication unpredictably, increases bruising, and can worsen injection site reactions

In addition to being a glucagon-like peptide-1 (GLP-1) receptor agonist, tirzepatide is also a glucose-dependent insulinotropic polypeptide (GIP) receptor

Schedule a consultation if you experience any signs of contraceptive failure while taking tirzepatide, including missed periods (if not expected with your contraceptive method), unusual bleeding patterns, or symptoms of early pregnancy such as breast tenderness, nausea beyond what is expected from tirzepatide, or fatigue